Objective: To present a case of intractable cryptogenic gelastic epilepsy with ictal video-EEG to localize the seizure focus. Clinical Presentation and Intervention: A 39-year-old female presented with a 2-year history of intractable gelastic epilepsy characterized by recurrent episodes of stereotyped pathological laughter, transient unresponsiveness, automatisms and brief postictal confusion. The patient failed to respond to multiple antiepileptic drugs. Several interictal EEGs did not show any abnormalities. Magnetic resonance imaging of the head with seizure protocol and diffusion tensor imaging were normal. Ictal video-EEG monitoring showed rhythmic, sharp activity emanating from the right temporal lobe. Conclusion: This case suggests that the right temporal lobe may be actively involved in the epileptogenic network generating gelastic epilepsy. Video-EEG monitoring should be considered for patients with gelastic epilepsies to better clarify the nature of events, localize the seizure focus and correlate EEG changes with the clinical manifestations.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.